Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World StudyWeersink, R. A., Taxis, K., Drenth, J. P. H., Houben, E., Metselaar, H. J. & Borgsteede, S. D., Apr-2019, In : Drug Safety. 42, 4, p. 539-546
Research output: Contribution to journal › Article › Academic › peer-review
Patients with cirrhosis are at risk for adverse drug reactions (ADRs) due to altered pharmacokinetics and pharmacodynamics. We aimed to determine the prevalence of drug prescriptions and the potential safety of these prescriptions in a real-world cohort of patients with cirrhosis.
|Early online date||24-Oct-2018|
|Publication status||Published - Apr-2019|
No data available